Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.95% is 20% below its 5-year average of 4.92%, near the low end of its 5-year range (3.21%–7.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 14.73% below its 12-month average of 4.64%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.95%.
DEBT TO ASSETS RATIO
3.95%
DEBT TO ASSETS RATIO AVG TTM
4.64%
DEBT TO ASSETS RATIO AVG 3Y
5.28%
DEBT TO ASSETS RATIO AVG 5Y
4.92%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-14.73%
CURRENT VS 3Y AVG
-25.08%
CURRENT VS 5Y AVG
-19.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 779 covered companies
CURRENT VS SECTOR MEDIAN
+4293.99%
vs the sector median at left
Gain Therapeutics, Inc.
Market Cap
$72.30M
Debt to Assets Ratio
3.95%
TTM Avg
4.64%
3Y Avg
5.28%
5Y Avg
4.92%
Market Cap
$70.30M
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.48M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.31M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.13M
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$68.27M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gain Therapeutics, Inc. (GANX) | $72.30M | 3.95% | 4.64% | 5.28% | 4.92% |
| Champions Oncology, Inc. (CSBR)vs › | $70.30M | 0.33% | N/A | N/A | N/A |
| Hyperfine, Inc. (HYPR)vs › | $75.09M | 0.21% | N/A | N/A | N/A |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 0.04% | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $69.31M | 0.20% | N/A | N/A | N/A |
| iBio, Inc. (IBIO)vs › | $68.81M | 0.02% | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.13M | 0.75% | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $68.27M | 0.20% | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.47M | 0.43% | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | 0.03% | N/A | N/A | N/A |
Debt/Assets
4.0%
Debt/Equity
0.05
Current Ratio
4.36
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.95% |
| 2026-03-31 | 3.59% |
| 2025-12-31 | 3.21% |
| 2025-09-30 | 5.52% |
| 2025-06-30 | 6.92% |
| 2025-03-31 | 5.22% |
| 2024-12-31 | 5.39% |
| 2024-09-30 | 5.36% |
| 2024-06-30 | 4.21% |
| 2024-03-31 | 6.10% |
| 2023-12-31 | 5.52% |
| 2023-09-30 | 7.37% |
| 2023-06-30 | 6.27% |
| 2023-03-31 | 5.66% |
| 2022-12-31 | 5.29% |
| 2022-09-30 | 4.48% |
| 2022-06-30 | 4.35% |
| 2022-03-31 | 3.98% |
| 2021-12-31 | 4.13% |
| 2021-09-30 | 3.42% |
| 2021-06-30 | 3.36% |
| 2021-03-31 | 2.54% |
| 2020-12-31 | 13.13% |
| 2020-09-30 | 8.64% |
| 2019-12-31 | 30.43% |
| 2019-09-30 | 30.43% |
| 2019-06-30 | 30.43% |
| 2019-03-31 | 30.43% |
